Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 184

The DOI matches its Crossref record.

Double‐Blind Randomized Controlled Trial of Glutamine‐Enriched Polymeric Diet in the Treatment of Active Crohn's Disease

Akobeng, Anthony K., Miller, Victor, Stanton, John, Elbadri, Abubaker M., Thomas, Adrian G.·2000·Journal of Pediatric Gastroenterology and Nutrition

Abstract

Background: Glutamine is traditionally considered a nonessential amino acid but may be conditionally essential in patients with catabolic conditions. Glutamine‐supplemented foods in these patients have been shown to prevent deterioration of gut permeability, protect against the development of intestinal mucosal atrophy, and improve nitrogen balance. Animal models of inflammatory bowel disease suggest that glutamine‐enriched enteral diets may lead to less severe intestinal damage, less weight loss, improved nitrogen balance, and reduced disease activity. The purpose of the current study was to compare the efficacy of a glutamine‐enriched polymeric diet with a standard low‐glutamine polymeric diet in the treatment of active Crohn's disease. Methods: Eighteen children with active Crohn's disease were randomly assigned to receive a 4‐week course of either a standard polymeric diet with a low glutamine content (4% of amino acid composition; group S) or a glutamine‐enriched polymeric diet (42% of amino acid composition; Group G). The two diets were isocaloric and isonitrogenous with an identical essential amino acid profile. Remission rates were analysed on an intent‐to‐treat basis. Changes in clinical and laboratory parameters of disease activity were also compared after 4 weeks of nutritional treatment. Results: Two of the children, both in group G, were withdrawn from the trial because of nontolerance of the diet. There was no difference between the two groups in proportion of patients achieving remission (intent‐to‐treat basis): 5 (55.5%) of 9 in group S versus 4 (44.4%) of 9 in group G (p = 0.5). Improvement in mean paediatric Crohn's disease activity index (PCDAI) was significantly more in group S (p = 0.002) but changes in orosomucoid level, platelet count, and weight were not different between the groups. Conclusions: The findings suggest that a glutamine‐enriched polymeric diet offers no advantage over a standard low‐glutamine polymeric diet in the treatment of active Crohn's disease. Rather, it appears to be less effective in improving PCDAI. The reported beneficial effects of glutamine seen in many catabolic states must be viewed with caution when extrapolating to the management of Crohn's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/j.1536-4801.2000.tb02658.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 184

Metadata

Authors
Akobeng, A. K., Miller, V., Stanton, J., Elbadri, A. M., & Thomas, A. G.
Venue
Journal of Pediatric Gastroenterology and Nutrition
Publisher
Wiley
Published
2000-01
Volume
30
Issue
1
Pages
78-84
ISSN
  • 0277-2116 (ISSN-L)
  • 1536-4801
OpenAlex
W2004925182
Cited by
184
References
0
FWCI
5.57
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Double‐Blind Randomized Controlled Trial of Glutamine‐Enriched Polymeric Diet in the Treatment of Active Crohn's Disease. https://app.cochat.ai/papers/10.1002/j.1536-4801.2000.tb02658.x
The paper
Akobeng, A. K., Miller, V., Stanton, J., Elbadri, A. M., & Thomas, A. G. (2000). Double‐Blind Randomized Controlled Trial of Glutamine‐Enriched Polymeric Diet in the Treatment of Active Crohn's Disease. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/j.1536-4801.2000.tb02658.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.